| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/17/2023 | Pyxis Oncology, Inc. | PYXS | Purchase | Common Stock, $0.001 par value per share | 1.8M | $2.76 | $5M | | 03/17/2023 |
| 03/17/2023 | Pyxis Oncology, Inc. | PYXS | Purchase | Common Stock, $0.001 par value per share | 1.8M | $2.76 | $5M | | 03/17/2023 |
| 12/18/2020 | BioAtla, Inc. | | Conversion | Common Stock | 2.2M | $0.00 | $0 | See Footnote(2) | 12/18/2020 |
| 12/18/2020 | BioAtla, Inc. | | Conversion | Series D Convertible Preferred Stock | 2.2M | $0.00 | $0 | See Footnote (2) | 12/18/2020 |
| 11/16/2020 | Viatris Inc | VTRS | Other (disposition) | Common Stock, par value $0.01 per share | 689.9M | $0.00 | $0 | | 11/13/2020 |
| 11/13/2020 | Viatris Inc | VTRS | Other (acquisition) | Common Stock, par value $0.01 per share | 689.9M | $0.00 | $0 | | 11/13/2020 |
| 10/27/2020 | Cerevel Therapeutics Holdings, Inc. | CERE | Purchase | Common Stock | 1.2M | $10.00 | $12M | | 10/27/2020 |
| 06/03/2020 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 370k | $40.18 | $14.9M | | 06/03/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Common Stock | 76k | $0.00 | $0 | | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Common Stock | 868.5k | $0.00 | $0 | By Pfizer Ventures (US) LLC | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Common Stock | 300.8k | $0.00 | $0 | By Pfizer Ventures (US) LLC | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common Stock | 312.5k | $16.00 | $5M | By Pfizer Ventures (US) LLC | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series Seed Preferred Stock | 478.7k | $0.00 | $0 | | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series A Preferred Stock | 5.5M | $0.00 | $0 | By Pfizer Ventures (US) LLC | 03/16/2020 |
| 03/16/2020 | Enliven Therapeutics, Inc. | IMRA | Conversion | Series B Preferred Stock | 1.9M | $0.00 | $0 | By Pfizer Ventures (US) LLC | 03/16/2020 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series B Convertible Preferred Stock | 3.5M | $0.00 | $0 | | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 978.2k | $0.00 | $0 | | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 3M | $0.00 | $0 | | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 526.6k | $0.00 | $0 | | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Purchase | Common Stock | 50k | $18.00 | $900k | | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Junior Series A Convertible Preferred Stock | 6.4M | $0.00 | $0 | | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series A Convertible Preferred Stock | 20M | $0.00 | $0 | | 09/17/2019 |
| 05/13/2019 | Quince Therapeutics, Inc. | CRTX | Conversion | Common Stock | 2.4M | $0.00 | $0 | | 05/13/2019 |
| 05/13/2019 | Quince Therapeutics, Inc. | CRTX | Conversion | Common Stock | 215.7k | $0.00 | $0 | | 05/13/2019 |
| 05/13/2019 | Quince Therapeutics, Inc. | CRTX | Conversion | Common Stock | 624.2k | $0.00 | $0 | | 05/13/2019 |
| 05/13/2019 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 50k | $17.00 | $850k | | 05/13/2019 |
| 05/13/2019 | Quince Therapeutics, Inc. | CRTX | Conversion | Series A Redeemable Convertible Preferred Stock | 2.4M | $0.00 | $0 | | 05/13/2019 |
| 05/13/2019 | Quince Therapeutics, Inc. | CRTX | Conversion | Series B Redeemable Convertible Preferred Stock | 215.7k | $0.00 | $0 | | 05/13/2019 |
| 05/13/2019 | Quince Therapeutics, Inc. | CRTX | Conversion | Series B Redeemable Convertible Preferred Stock | 624.2k | $0.00 | $0 | | 05/13/2019 |
| 11/15/2018 | ICU MEDICAL INC/DE | ICUI | Sale | Common Stock | 2.5M | $209.25 | $523.1M | - | 11/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Series A-1 Convertible Preferred Stock | 4.2M | $0.00 | $0 | | 10/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Purchase | Common Stock | 55.6k | $18.00 | $1M | | 10/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Common Stock | 22M | $0.00 | $0 | | 10/15/2018 |
| 08/13/2018 | ICU MEDICAL INC/DE | ICUI | Sale | Common Stock | 700k | $284.35 | $199M | _ | 08/13/2018 |
| 10/10/2017 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Conversion | Common Stock | 447.5k | $0.00 | $0 | | 10/10/2017 |
|